# AbCellera Biologics Inc.: Form 8-K, filed Oct 13, 2023

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2023-10-13
- Accepted by EDGAR: Oct 12, 2023, 20:03 ET
- Period: 2023-09-18
- Accession: 0001703057-23-000034
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000034/abcl-20230918.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000034/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000170305723000034/abcl-20230918.htm

Filed Oct 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001703057-23-000034. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
